Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment
about
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionTraumatic brain injury, neuroimaging, and neurodegeneration2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Longitudinal trajectories of everyday function by diagnostic status.Adverse Effects of the Apolipoprotein E ε4 Allele on Episodic Memory, Task Switching and Gray Matter Volume in Healthy Young AdultsRegional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum.The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairmentFunction and comorbidities of apolipoprotein e in Alzheimer's disease.Longitudinal declines in instrumental activities of daily living in stable and progressive mild cognitive impairmentInteractive effects of apolipoprotein E4 and diabetes risk on later myelinating white matter regions in neurologically healthy older aged adultsApolipoprotein E ε2 and functional decline in amnestic mild cognitive impairment and Alzheimer disease.Globalization of Alzheimer's disease clinical trialsSelf-rated and informant-rated everyday function in comparison to objective markers of Alzheimer's disease.Reduced Gray Matter Volume Is Associated With Poorer Instrumental Activities of Daily Living Performance in Heart Failure.BACE1 as a potential biomarker for Alzheimer's diseaseOccupational Complexity and Cognitive Reserve in a Middle-Aged Cohort at Risk for Alzheimer's Disease.Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease?Apolipoprotein E ε4 is superior to apolipoprotein E ε2 in predicting cognitive scores over 30 months.Multistage Grading of Amnestic Mild Cognitive Impairment: The Associated Brain Gray Matter Volume and Cognitive Behavior CharacterizationA qualitative review of instrumental activities of daily living in dementia: what's cooking?Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.Advances in clinical neuroimaging: implications for autism spectrum disorders.Mild cognitive impairment (MCI) twenty years on.
P2860
Q27006831-2E7F62BA-0F36-4F62-B7BF-732BE0EEE392Q28386903-707D746E-CA12-4F87-916D-E28B3AA5EF58Q30971403-84194868-8615-453D-9AEF-77CDC7B97EB0Q33614486-92F735A0-C235-4DF4-B297-455CB227D4F3Q33849832-4113D043-F569-4F8A-BD2A-67986C1DCA70Q33953180-292FF7EE-20FE-4366-B3CA-82ABB3897BD2Q34065449-1953FE77-8AAE-452C-B413-589336A152F9Q34180267-25521993-682E-4EA2-AD16-99E9B88C390AQ34951817-E3669CA3-1748-4A3D-9631-74BF92B84081Q35033715-B0E40241-F7B0-4049-81D2-D3F6B2F0D4E6Q35167347-59EF1310-3C71-4A15-BC19-C4996460FBACQ35281905-D7D977DC-C276-4630-865C-FF9884B7AEE1Q35579247-FAE963BF-C20C-48D6-9FFE-05389A6CB38BQ35611460-50075AC0-26C2-4AC6-98B8-42E57D48C22AQ35634740-AC5B3AEE-3905-4DE1-9D31-0FF47EAEFC26Q35856328-37556F05-7AC5-4BEC-A742-166FC3F22471Q36160858-C21C94A7-1937-4E22-8282-A2CFD21562B1Q36755789-D732EB82-254E-4D0B-BC2E-7B0E0A4A7B20Q37278806-7C124F6A-3ADA-4EAD-87C2-67D3C1ABFB9FQ37574919-4FA691BE-D07F-43C6-B0BB-5358CA7973B9Q38269098-7DA0B0FA-9AC3-45D2-A37C-E6267787CB18Q38858239-489BE051-5EE4-4BA2-9D53-4F49C357B202Q48811065-994EF0BC-8540-41A9-905B-23C059746065Q54000552-C1AD07AF-E415-4534-8986-01357BAF1494
P2860
Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cerebral atrophy, apolipoprote ...... stic mild cognitive impairment
@ast
Cerebral atrophy, apolipoprote ...... stic mild cognitive impairment
@en
Cerebral atrophy, apolipoprote ...... stic mild cognitive impairment
@nl
type
label
Cerebral atrophy, apolipoprote ...... stic mild cognitive impairment
@ast
Cerebral atrophy, apolipoprote ...... stic mild cognitive impairment
@en
Cerebral atrophy, apolipoprote ...... stic mild cognitive impairment
@nl
prefLabel
Cerebral atrophy, apolipoprote ...... stic mild cognitive impairment
@ast
Cerebral atrophy, apolipoprote ...... stic mild cognitive impairment
@en
Cerebral atrophy, apolipoprote ...... stic mild cognitive impairment
@nl
P2093
P2860
P1476
Cerebral atrophy, apolipoprote ...... stic mild cognitive impairment
@en
P2093
Beth A Jerskey
Brian R Ott
Geoffrey Tremont
Lawrence H Sweet
Michael L Alosco
Ozioma C Okonkwo
P2860
P304
P356
10.1016/J.JALZ.2010.02.003
P577
2010-09-01T00:00:00Z